CMS finalizes Medicare fee schedule for Myomo's MyoPro at $33,481-$65,872 per device

MYOMO, INC.

CMS final fee schedule rates: L8701 (Motion W) $33,480.90, L8702 (Motion G) $65,871.74, effective April 1, 2024.
MyoPro classified as brace benefit category on Jan 1, 2024, enabling lump-sum reimbursement.
CEO Paul Gudonis calls it 'important milestone' for Medicare Part B beneficiaries and the company.
Process started in 2018 with HCPCS coding; now final rates enable billing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.